Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

NCT03853369 · clinicaltrials.gov ↗

UNKNOWN

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Ventricular Tachycardia
Ventricular Fibrillation

Interventions

DRUG: Nifekalant hydrochloride

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]